BRIEF published on 03/13/2024 at 14:05, 2 years ago NovaSight Reports Significant Long-Term Vision Improvements with CureSight Treatment NovaSight CureSight Amblyopia Treatment Digital Eyecare Pediatric Vision
PRESS RELEASE published on 03/13/2024 at 14:00, 2 years ago NovaSight Announces Publication of CureSight(TM)'s Pivotal Study of One-Year Follow-Up Outcomes Study in American Journal of Ophthalmology shows long-term visual acuity gains with NovaSight's CureSight treatment for amblyopia in kids. Pivotal trial demonstrates significant improvement NovaSight CureSight Treatment Amblyopia Visual Acuity Gains Binocular Treatment
PRESS RELEASE published on 06/27/2023 at 15:15, 2 years 9 months ago Ophthalmic Office-Based Surgery Safety Study Published in Peer Review Journal
Published on 04/09/2026 at 16:00, 46 minutes ago Banff Half Marathon Completes 2025 Emissions Assessment, Supporting Climate Action with Karbon-X
Published on 04/09/2026 at 14:40, 2 hours 6 minutes ago Silver X Delivers Production Growth During the First Quarter of 2026
Published on 04/09/2026 at 14:00, 2 hours 46 minutes ago Orogen Royalties Announces Mineral Reserve and Resource Update on Producing Ermitaño Royalty
Published on 04/09/2026 at 13:30, 3 hours 16 minutes ago Datametrex Receives $6M Purchase Order for Data Centre from Fortune 500 Conglomerate
Published on 04/09/2026 at 13:30, 3 hours 16 minutes ago ESGold Advances Toward Production and Exploration Drilling as Mill Buildout Progresses in Parallel
Published on 04/09/2026 at 15:40, 1 hour 6 minutes ago Form 8.3 - The Vanguard Group, Inc.: LondonMetric Property plc
Published on 04/09/2026 at 15:39, 1 hour 6 minutes ago Form 8.3 - The Vanguard Group, Inc.: Schroders plc
Published on 04/09/2026 at 15:39, 1 hour 7 minutes ago Form 8.3 - The Vanguard Group, Inc.: British Land Company plc, The
Published on 04/09/2026 at 15:57, 48 minutes ago Filing of CNP Assurances SA 2025 universal registration document and 2025 Solvency and Financial Condition Reports
Published on 04/09/2026 at 07:00, 9 hours 46 minutes ago bioMérieux Unveils its BIOFIRE® SPOTFIRE® Molecular Testing Solution for the Pharmaceutical Industry, Redefining Rapid Mycoplasma Testing
Published on 04/08/2026 at 18:02, 22 hours 44 minutes ago Publication of the 2025 Universal Registration Document
Published on 04/08/2026 at 17:45, 23 hours 1 minute ago DISCLOSURE OF SHARE CAPITAL AND VOTING RIGHTS
Published on 04/08/2026 at 12:58, 1 day 3 hours ago EURAZEO IS ASSIGNED A BBB CREDIT RATING (STABLE OUTLOOK) BY S&P AND A BBB CREDIT RATING (STABLE OUTLOOK) BY FITCH
